Warning letter
Baptist Women's Pavilion Hospital: warning letter of Apr 14, 2003
FDA warning letter UCM147430 · New Orleans District Office
Key facts
| Reference number | UCM147430 |
|---|---|
| Company | Baptist Women's Pavilion Hospital |
| Subject | Mammography Quality Standards |
| Issue date | Apr 14, 2003 |
| Posted date | Apr 14, 2003 |
| Issuing office | New Orleans District Office |
| Product type | Devices |
| CFR sections cited | 900.12(b), 900, 900.12(e)(1)(i), 900.12 |
| Country | 3 |
| Inspection city | Nashville |
| Inspection ZIP | 37203-2121 |
| Inspection start date | Mar 25, 2003 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: